InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…
Italy’s antitrust regulator has widened its investigation into Meta Platforms after identifying new concerns linked to the company’s artificial intelligence…